Gemina Laboratories Launches Private Placement Offering

Gemina Laboratories Ltd., based in Vancouver, has announced a private placement of common shares, exclusively available to existing shareholders. This follows the successful raising of $3 million in December 2025 through a debenture offering, enabling the company to restructure its debt, totaling over $6.2 million.

The private placement seeks to generate between $500,000 and $1.5 million to repay debts and fund performance studies comparing Gemina's technologies with leading industry solutions. This placement is exclusively for shareholders in Canada, with a hold period of four months and one day.

Gemina plans to settle $3 million in debentures for common shares, conditional on raising $1.5 million in the current offering. This strategic move aims to release the company's intellectual property from debenture holders, further supporting their growth and development initiatives.